These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Agonists and antagonists for P2 receptors. Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423 [TBL] [Abstract][Full Text] [Related]
7. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors. Ryu JK; Kim J; Choi SH; Oh YJ; Lee YB; Kim SU; Jin BK Neuroreport; 2002 Sep; 13(13):1611-5. PubMed ID: 12352612 [TBL] [Abstract][Full Text] [Related]
8. Ribose modified nucleosides and nucleotides as ligands for purine receptors. Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046 [TBL] [Abstract][Full Text] [Related]
9. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation. Washburn KB; Neary JT Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269 [TBL] [Abstract][Full Text] [Related]
10. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation. Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494 [TBL] [Abstract][Full Text] [Related]
11. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner. Yu Y; Zhang C Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349 [TBL] [Abstract][Full Text] [Related]
12. Purinergic signaling in kidney disease. Menzies RI; Tam FW; Unwin RJ; Bailey MA Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585 [TBL] [Abstract][Full Text] [Related]
13. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors. Jacobson KA; Kim YC; Wildman SS; Mohanram A; Harden TK; Boyer JL; King BF; Burnstock G J Med Chem; 1998 Jun; 41(13):2201-6. PubMed ID: 9632352 [TBL] [Abstract][Full Text] [Related]
14. Purine and pyrimidine receptors. Burnstock G Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261 [TBL] [Abstract][Full Text] [Related]
15. New paradigms in purinergic receptor ligand discovery. Jacobson KA; Pradhan B; Wen Z; Pramanik A Neuropharmacology; 2023 Jun; 230():109503. PubMed ID: 36921890 [TBL] [Abstract][Full Text] [Related]
16. Action of natural products on p2 receptors: a reinvented era for drug discovery. Faria R; Ferreira L; Bezerra R; Frutuoso V; Alves L Molecules; 2012 Nov; 17(11):13009-25. PubMed ID: 23117439 [TBL] [Abstract][Full Text] [Related]
17. Involvement of purinergic signaling in cardiovascular diseases. Ralevic V; Burnstock G Drug News Perspect; 2003 Apr; 16(3):133-40. PubMed ID: 12819811 [TBL] [Abstract][Full Text] [Related]